iA Global Asset Management Inc. decreased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 14.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,671 shares of the insurance provider's stock after selling 2,344 shares during the quarter. iA Global Asset Management Inc.'s holdings in Humana were worth $4,330,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Capital Advisors Ltd. LLC increased its holdings in shares of Humana by 17.0% in the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider's stock worth $80,000 after acquiring an additional 31 shares in the last quarter. CarsonAllaria Wealth Management Ltd. increased its stake in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Moors & Cabot Inc. raised its holdings in Humana by 2.5% during the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider's stock worth $519,000 after buying an additional 40 shares during the period. Harbour Investments Inc. lifted its stake in Humana by 10.5% in the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider's stock valued at $161,000 after buying an additional 41 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft boosted its holdings in shares of Humana by 1.0% in the second quarter. Baader Bank Aktiengesellschaft now owns 4,421 shares of the insurance provider's stock valued at $1,649,000 after buying an additional 42 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.
Analyst Ratings Changes
Several research firms recently commented on HUM. JPMorgan Chase & Co. boosted their price objective on shares of Humana from $332.00 to $396.00 and gave the company a "neutral" rating in a research report on Wednesday, August 21st. Cantor Fitzgerald reissued a "neutral" rating and issued a $395.00 price target on shares of Humana in a research note on Tuesday, October 1st. Barclays upped their price objective on Humana from $250.00 to $253.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 31st. Oppenheimer dropped their target price on Humana from $400.00 to $280.00 and set an "outperform" rating on the stock in a research report on Thursday, October 3rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on Humana from $349.00 to $250.00 and set a "hold" rating for the company in a research report on Thursday, October 3rd. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $315.86.
Check Out Our Latest Report on HUM
Humana Stock Performance
Shares of Humana stock traded down $1.33 on Friday, hitting $281.73. The stock had a trading volume of 1,751,061 shares, compared to its average volume of 1,590,764. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $488.89. The business's 50 day moving average is $272.68 and its two-hundred day moving average is $326.83. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market cap of $33.92 billion, a price-to-earnings ratio of 24.95, a price-to-earnings-growth ratio of 2.27 and a beta of 0.53.
Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Analysts forecast that Humana Inc. will post 16.14 EPS for the current year.
Humana Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.26%. The ex-dividend date is Tuesday, December 31st. Humana's payout ratio is 31.36%.
Humana Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
